Latvia Flu Update: Cases Declining But Remain at Epidemic Levels – March 2024

Influenza activity in Latvia remains at epidemic levels, though showing early signs of easing, according to the Disease Prevention and Control Centre (SPKC). Although the rate of confirmed cases has decreased slightly in the last week, the country is still experiencing widespread flu transmission, particularly among children.

The latest data, reported on March 18th by LETA news agency, indicates that 10.1% of samples tested at the National Microbiology Reference Laboratory were positive for influenza last week. What we have is down from 15.5% the previous week, suggesting a potential peak has passed. Almost all confirmed cases are influenza A viruses, with only two cases of influenza B identified.

Incidence Rates and Regional Variation

The incidence of influenza in outpatient medical facilities also declined last week, falling to 57.6 cases per 100,000 residents, compared to 110.6 cases per 100,000 the week prior. Still, flu cases were detected in nine of ten monitoring regions, indicating broad geographic spread. The municipality of Gulbene currently reports the highest incidence rate within the country. Notably, children under 14 years of age continue to be disproportionately affected by the current outbreak.

Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and lungs. Symptoms can range from mild to severe and can include fever, cough, sore throat, muscle aches, headache, and fatigue. Complications, such as pneumonia, can be serious, especially for vulnerable populations like young children, the elderly, and individuals with underlying health conditions. More information about influenza and its symptoms can be found on the Centers for Disease Control and Prevention (CDC) website.

Mortality and Ongoing Surveillance

Tragically, three additional deaths among patients with confirmed influenza infection were reported last week, bringing the total number of influenza-related deaths reported since the start of the season to 47. It’s important to note that these figures represent reported cases and may not reflect the full extent of influenza-related mortality in Latvia.

The SPKC continues to actively monitor influenza activity through laboratory surveillance, tracking of outpatient visits, and reporting of severe cases and deaths. This ongoing surveillance is crucial for understanding the evolving dynamics of the outbreak and informing public health recommendations. The European Centre for Disease Prevention and Control (ECDC) also provides regular updates on influenza activity across Europe, including risk assessments and guidance for member states.

Understanding the Data: Limitations and Context

While the declining incidence rates are encouraging, it’s important to interpret these figures with caution. Laboratory confirmation rates can be influenced by testing practices and access to healthcare. A decrease in testing may lead to an underestimation of the true number of cases. The reported mortality figures only include cases where influenza was confirmed as a contributing factor, and many influenza-related deaths may go unrecorded.

The dominance of influenza A viruses in the current outbreak is consistent with global trends. Influenza viruses are constantly evolving, and new strains emerge regularly. The composition of influenza vaccines is updated annually to match the circulating strains, but vaccine effectiveness can vary depending on the match between the vaccine and the circulating viruses. The World Health Organization (WHO) provides detailed information on influenza viruses and vaccine development.

What Factors Contribute to Epidemic Levels?

Several factors can contribute to influenza reaching epidemic levels. These include low population immunity (due to lack of prior exposure or vaccination), the emergence of novel viral strains, and increased social mixing during the colder months. Public health measures, such as vaccination campaigns, promotion of respiratory hygiene, and social distancing, can help to mitigate the spread of influenza.

What Comes Next: Public Health Response and Guidance

The SPKC continues to recommend vaccination as the most effective way to prevent influenza and its complications. Individuals at high risk of severe illness, including young children, the elderly, pregnant women, and people with chronic health conditions, are particularly encouraged to gain vaccinated. In addition to vaccination, the SPKC advises individuals to practice good respiratory hygiene, such as covering coughs and sneezes with a tissue, washing hands frequently, and staying home when sick.

The current situation will continue to be closely monitored, and public health recommendations may be adjusted as needed based on the evolving dynamics of the outbreak. Regular updates and guidance can be found on the SPKC website. Individuals experiencing flu-like symptoms should consult with a healthcare professional for diagnosis and treatment. It is also important to remember that other respiratory viruses, such as respiratory syncytial virus (RSV) and COVID-19, are also circulating, and symptoms can overlap. Testing may be necessary to determine the specific cause of illness.